Oppenheimer & Co. Inc. Trims Stock Position in Encompass Health Co. (NYSE:EHC)

Oppenheimer & Co. Inc. cut its position in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 4.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 100,770 shares of the company's stock after selling 4,241 shares during the quarter. Oppenheimer & Co. Inc. owned approximately 0.10% of Encompass Health worth $9,306,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of EHC. Point72 Asset Management L.P. increased its holdings in shares of Encompass Health by 2,458.5% in the third quarter. Point72 Asset Management L.P. now owns 869,104 shares of the company's stock worth $83,990,000 after buying an additional 835,135 shares during the period. Jennison Associates LLC bought a new stake in Encompass Health in the fourth quarter valued at approximately $52,094,000. abrdn plc bought a new position in shares of Encompass Health in the fourth quarter worth approximately $17,846,000. Thrivent Financial for Lutherans raised its holdings in Encompass Health by 26.0% during the 3rd quarter. Thrivent Financial for Lutherans now owns 760,496 shares of the company's stock valued at $73,494,000 after buying an additional 156,938 shares during the last quarter. Finally, Franklin Resources Inc. boosted its position in Encompass Health by 22.0% during the 3rd quarter. Franklin Resources Inc. now owns 700,021 shares of the company's stock valued at $67,412,000 after buying an additional 126,000 shares during the period. 97.25% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Encompass Health

In other news, CAO Andrew L. Price sold 5,042 shares of the business's stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total value of $495,578.18. Following the completion of the transaction, the chief accounting officer now owns 69,164 shares in the company, valued at $6,798,129.56. The trade was a 6.79 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 2.10% of the company's stock.

Remove Ads

Analysts Set New Price Targets

Several research firms recently issued reports on EHC. StockNews.com raised Encompass Health from a "hold" rating to a "buy" rating in a research note on Saturday, February 15th. Barclays boosted their target price on Encompass Health from $116.00 to $118.00 and gave the company an "overweight" rating in a research note on Friday, February 7th. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $110.00 price target on shares of Encompass Health in a research note on Tuesday, February 11th. KeyCorp boosted their price objective on shares of Encompass Health from $117.00 to $120.00 and gave the company an "overweight" rating in a research report on Monday, February 10th. Finally, William Blair reaffirmed an "outperform" rating on shares of Encompass Health in a research report on Friday, February 7th. Ten investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Buy" and an average price target of $107.67.

Encompass Health Stock Down 0.4 %

NYSE EHC traded down $0.41 during trading hours on Monday, reaching $99.73. 681,585 shares of the company's stock traded hands, compared to its average volume of 658,644. The firm has a market cap of $10.05 billion, a PE ratio of 22.36, a PEG ratio of 2.31 and a beta of 0.90. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.05 and a quick ratio of 1.04. Encompass Health Co. has a 52-week low of $74.27 and a 52-week high of $104.55. The firm has a 50-day simple moving average of $96.42 and a 200 day simple moving average of $96.42.

Encompass Health (NYSE:EHC - Get Free Report) last issued its quarterly earnings results on Thursday, February 6th. The company reported $1.17 EPS for the quarter, topping analysts' consensus estimates of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. Sell-side analysts anticipate that Encompass Health Co. will post 4.8 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, April 17th. Shareholders of record on Tuesday, April 1st will be issued a $0.17 dividend. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $0.68 annualized dividend and a yield of 0.68%. Encompass Health's dividend payout ratio (DPR) is presently 15.25%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.